Hydrazine and Lupus

Pamela J. Durant, Robert A. Harris

Research output: Contribution to journalLetter

17 Citations (Scopus)

Abstract

To the Editor: We wish to bring to the attention of physicians and laboratory and industrial workers the possibility that hydrazine may induce a syndrome similar to systemic lupus erythematosus. Certain other drugs, such as hydralazine, have been known to induce such a syndrome. According to their molecular structures, hydrazine (NH2NH2) corresponds to the chemically reactive portion of the hydralazine molecule (NHNH2). Hydrazine sulfate has been used routinely in our laboratory for the enzymatic determination of lactate, 1 malate, 2 and beta-hydroxybutyrate.3 After these assays had been used on a regular basis in the laboratory for.

Original languageEnglish (US)
Pages (from-to)584-585
Number of pages2
JournalNew England Journal of Medicine
Volume303
Issue number10
DOIs
StatePublished - Sep 4 1980

Fingerprint

hydrazine
Hydrazines
Occupational Diseases
Systemic Lupus Erythematosus
Hydralazine
Medical Societies
Molecular Structure
Lactic Acid
Physicians
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Hydrazine and Lupus. / Durant, Pamela J.; Harris, Robert A.

In: New England Journal of Medicine, Vol. 303, No. 10, 04.09.1980, p. 584-585.

Research output: Contribution to journalLetter

Durant, Pamela J. ; Harris, Robert A. / Hydrazine and Lupus. In: New England Journal of Medicine. 1980 ; Vol. 303, No. 10. pp. 584-585.
@article{bd587566ce0b4c3eae4fee8f60f268a4,
title = "Hydrazine and Lupus",
abstract = "To the Editor: We wish to bring to the attention of physicians and laboratory and industrial workers the possibility that hydrazine may induce a syndrome similar to systemic lupus erythematosus. Certain other drugs, such as hydralazine, have been known to induce such a syndrome. According to their molecular structures, hydrazine (NH2NH2) corresponds to the chemically reactive portion of the hydralazine molecule (NHNH2). Hydrazine sulfate has been used routinely in our laboratory for the enzymatic determination of lactate, 1 malate, 2 and beta-hydroxybutyrate.3 After these assays had been used on a regular basis in the laboratory for.",
author = "Durant, {Pamela J.} and Harris, {Robert A.}",
year = "1980",
month = "9",
day = "4",
doi = "10.1056/NEJM198009043031017",
language = "English (US)",
volume = "303",
pages = "584--585",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "10",

}

TY - JOUR

T1 - Hydrazine and Lupus

AU - Durant, Pamela J.

AU - Harris, Robert A.

PY - 1980/9/4

Y1 - 1980/9/4

N2 - To the Editor: We wish to bring to the attention of physicians and laboratory and industrial workers the possibility that hydrazine may induce a syndrome similar to systemic lupus erythematosus. Certain other drugs, such as hydralazine, have been known to induce such a syndrome. According to their molecular structures, hydrazine (NH2NH2) corresponds to the chemically reactive portion of the hydralazine molecule (NHNH2). Hydrazine sulfate has been used routinely in our laboratory for the enzymatic determination of lactate, 1 malate, 2 and beta-hydroxybutyrate.3 After these assays had been used on a regular basis in the laboratory for.

AB - To the Editor: We wish to bring to the attention of physicians and laboratory and industrial workers the possibility that hydrazine may induce a syndrome similar to systemic lupus erythematosus. Certain other drugs, such as hydralazine, have been known to induce such a syndrome. According to their molecular structures, hydrazine (NH2NH2) corresponds to the chemically reactive portion of the hydralazine molecule (NHNH2). Hydrazine sulfate has been used routinely in our laboratory for the enzymatic determination of lactate, 1 malate, 2 and beta-hydroxybutyrate.3 After these assays had been used on a regular basis in the laboratory for.

UR - http://www.scopus.com/inward/record.url?scp=0018942458&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018942458&partnerID=8YFLogxK

U2 - 10.1056/NEJM198009043031017

DO - 10.1056/NEJM198009043031017

M3 - Letter

C2 - 7402226

AN - SCOPUS:0018942458

VL - 303

SP - 584

EP - 585

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 10

ER -